Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The New Jersey Innovation Evergreen Fund (NJIEF) is a state-sponsored venture capital fund designed to catalyze investment in New Jersey's high-growth technology and life sciences sectors. Managed by the New Jersey Economic Development Authority (NJEDA), the fund is uniquely structured to raise capital through the auction of state tax credits to established corporations. These corporate partners not only provide funding but also offer strategic mentorship and networking opportunities to the startups in the fund's portfolio. NJIEF co-invests alongside professional venture capital firms in early-stage businesses, aiming to deploy up to $600 million to support the state's innovation economy. The fund targets key industries including biotechnology, pharmaceuticals, and clean energy to foster long-term economic growth.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Jersey Innovation Evergreen Fund.